| Product NDC: | 65649-601 |
| Proprietary Name: | Visicol |
| Non Proprietary Name: | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS |
| Active Ingredient(s): | .398; 1.102 g/1; g/1 & nbsp; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65649-601 |
| Labeler Name: | Salix Pharmaceuticals, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021097 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20001001 |
| Package NDC: | 65649-601-04 |
| Package Description: | 40 TABLET in 1 BOTTLE (65649-601-04) |
| NDC Code | 65649-601-04 |
| Proprietary Name | Visicol |
| Package Description | 40 TABLET in 1 BOTTLE (65649-601-04) |
| Product NDC | 65649-601 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, AND SODIUM PHOSPHATE, DIBASIC ANHYDROUS |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20001001 |
| Marketing Category Name | NDA |
| Labeler Name | Salix Pharmaceuticals, Inc |
| Substance Name | SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Strength Number | .398; 1.102 |
| Strength Unit | g/1; g/1 |
| Pharmaceutical Classes |